-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Short Interest in Cellebrite DI Ltd. (NASDAQ:CLBT) Expands By 12.3%
Short Interest in Cellebrite DI Ltd. (NASDAQ:CLBT) Expands By 12.3%
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 1,730,000 shares, a growth of 12.3% from the August 15th total of 1,540,000 shares. Currently, 4.8% of the shares of the company are sold short. Based on an average trading volume of 126,600 shares, the short-interest ratio is currently 13.7 days.
Institutional Investors Weigh In On Cellebrite DI
Several hedge funds and other institutional investors have recently modified their holdings of CLBT. Blair William & Co. IL acquired a new stake in shares of Cellebrite DI in the fourth quarter worth $135,000. Diametric Capital LP bought a new position in Cellebrite DI in the fourth quarter worth $209,000. ETF Managers Group LLC bought a new position in Cellebrite DI in the fourth quarter worth $462,000. Greenhaven Road Investment Management L.P. bought a new position in Cellebrite DI in the fourth quarter worth $9,453,000. Finally, Yarbrough Capital LLC bought a new position in Cellebrite DI in the first quarter worth $414,000. Institutional investors and hedge funds own 20.41% of the company's stock.
Get Cellebrite DI alerts:Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on CLBT. Needham & Company LLC increased their target price on shares of Cellebrite DI from $6.00 to $6.50 and gave the company a "buy" rating in a research report on Thursday, August 11th. Cowen reduced their price objective on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research report on Friday, August 12th. Bank of America lowered shares of Cellebrite DI from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $6.50 to $6.00 in a research note on Friday, August 12th. Cowen reduced their price objective on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. Finally, William Blair lowered shares of Cellebrite DI from an "outperform" rating to a "market perform" rating in a research report on Friday, August 12th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $9.71.
Cellebrite DI Stock Down 1.8 %
Shares of CLBT stock opened at $4.21 on Wednesday. Cellebrite DI has a 12 month low of $4.10 and a 12 month high of $11.60. The business's 50 day moving average is $5.07 and its two-hundred day moving average is $5.36. The company has a market cap of $793.75 million, a PE ratio of 5.69, a price-to-earnings-growth ratio of 10.14 and a beta of 0.87.Cellebrite DI Company Profile
(Get Rating)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Read More
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You're Hungry for Value, Take a Bite on Ruth's Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 1,730,000 shares, a growth of 12.3% from the August 15th total of 1,540,000 shares. Currently, 4.8% of the shares of the company are sold short. Based on an average trading volume of 126,600 shares, the short-interest ratio is currently 13.7 days.
凱萊布里特DI有限公司(納斯達克代碼:CLBT-GET評級)是空頭股數在8月份實現顯著增長的目標。截至8月31日,空頭股數共有1,730,000股,較8月15日的1,540,000股增長12.3%。目前,該公司4.8%的股份被賣空。以12.66萬股的平均成交量計算,目前短息比率為13.7天。
Institutional Investors Weigh In On Cellebrite DI
機構投資者看好Cellebrite DI
Several hedge funds and other institutional investors have recently modified their holdings of CLBT. Blair William & Co. IL acquired a new stake in shares of Cellebrite DI in the fourth quarter worth $135,000. Diametric Capital LP bought a new position in Cellebrite DI in the fourth quarter worth $209,000. ETF Managers Group LLC bought a new position in Cellebrite DI in the fourth quarter worth $462,000. Greenhaven Road Investment Management L.P. bought a new position in Cellebrite DI in the fourth quarter worth $9,453,000. Finally, Yarbrough Capital LLC bought a new position in Cellebrite DI in the first quarter worth $414,000. Institutional investors and hedge funds own 20.41% of the company's stock.
幾家對衝基金和其他機構投資者最近調整了對CLBT的持股。Blair William&Co.IL在第四季度收購了價值13.5萬美元的Cellebrite DI新股。Diameter Capital LP在第四季度購買了Cellebrite DI的一個新頭寸,價值20.9萬美元。ETF Manager Group LLC在第四季度購買了Cellebrite DI的新頭寸,價值46.2萬美元。Greenaven Road Investment Management L.P.在第四季度購買了Cellebrite DI的一個新頭寸,價值9,453,000美元。最後,Yarbough Capital LLC在第一季度購買了Cellebrite DI的一個新頭寸,價值41.4萬美元。機構投資者和對衝基金持有該公司20.41%的股票。
Analyst Upgrades and Downgrades
分析師升級和下調評級
A number of brokerages recently issued reports on CLBT. Needham & Company LLC increased their target price on shares of Cellebrite DI from $6.00 to $6.50 and gave the company a "buy" rating in a research report on Thursday, August 11th. Cowen reduced their price objective on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research report on Friday, August 12th. Bank of America lowered shares of Cellebrite DI from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $6.50 to $6.00 in a research note on Friday, August 12th. Cowen reduced their price objective on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. Finally, William Blair lowered shares of Cellebrite DI from an "outperform" rating to a "market perform" rating in a research report on Friday, August 12th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $9.71.
多家券商近日發佈了關於CLBT的報告。Needham&Company LLC在8月11日星期四的一份研究報告中將Cellebrite DI的目標價從6.00美元上調至6.50美元,並給予該公司“買入”評級。考恩在8月12日星期五的一份研究報告中將Cellebrite DI的股票目標價從13.00美元下調至10.00美元,併為該公司設定了“跑贏大盤”的評級。在8月12日星期五的一份研究報告中,美國銀行將Cellebrite DI的股票評級從買入下調至中性,並將該公司的目標價從6.50美元下調至6.00美元。考恩在8月12日星期五的一份研究報告中將Cellebrite DI的股票目標價從13.00美元下調至10.00美元,併為該公司設定了“跑贏大盤”的評級。最後,在8月12日星期五的一份研究報告中,威廉·布萊爾將Cellebrite DI的股票評級從“跑贏大盤”下調至“市場表現”。兩名股票研究分析師對該股的評級為持有,六名分析師對該公司的評級為買入。根據MarketBeat的數據,該公司的普遍評級為“適度買入”,平均目標價為9.71美元。
Cellebrite DI Stock Down 1.8 %
Cellebrite DI股價下跌1.8%
Cellebrite DI Company Profile
Cellebrite DI公司簡介
(Get Rating)
(獲取評級)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Cellebrite DI Ltd.為法律批准的調查開發解決方案。其DI平臺允許用户在整個調查生命週期中收集、審查、分析和管理與法律批准的調查有關的數字數據,並在各種案件中使用解決方案,包括剝削兒童、兇殺、反恐、邊境控制、性犯罪、人口販運、企業安全、知識產權盜竊和民事訴訟。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You're Hungry for Value, Take a Bite on Ruth's Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
- 免費獲取StockNews.com關於Cellebrite DI(CLBT)的研究報告
- 3家航空公司股票陷入持有格局
- Roku股票下跌,但並未出局
- 如果你渴望價值,那就嚐嚐露絲的好客之道吧
- 福特在第三季度發出警告後是否正在反彈
- AMD股票是不是跌得太厲害了?
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
接受《凱爾布賴特DI日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cellebrite DI和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧